MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:MDA - CA55293N1096 - Common Stock
24.18 CAD
+0.62 (+2.63%)
Overall MDA gets a fundamental rating of 6 out of 10. We evaluated MDA against 10 industry peers in the Aerospace & Defense industry. MDA has only an average score on both its financial health and profitability. MDA is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year MDA was profitable.
In the past year MDA had a positive cash flow from operations.
Of the past 5 years MDA 4 years were profitable.
In the past 5 years MDA always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 3.63%, MDA belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 8.94%, MDA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.72%, MDA is doing worse than 60.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MDA is below the industry average of 8.50%.
The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 8.94% | ||
| ROIC | 5.72% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
MDA's Profit Margin of 8.48% is amongst the best of the industry. MDA outperforms 90.00% of its industry peers.
MDA's Profit Margin has improved in the last couple of years.
MDA has a Operating Margin of 10.97%. This is in the lower half of the industry: MDA underperforms 60.00% of its industry peers.
MDA's Operating Margin has improved in the last couple of years.
The Gross Margin of MDA (24.54%) is better than 70.00% of its industry peers.
MDA's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.97% | ||
| PM (TTM) | 8.48% | ||
| GM | 24.54% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDA is destroying value.
MDA has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, MDA has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.58, we must say that MDA is in the distress zone and has some risk of bankruptcy.
MDA has a Altman-Z score of 1.58. This is in the better half of the industry: MDA outperforms 80.00% of its industry peers.
The Debt to FCF ratio of MDA is 0.55, which is an excellent value as it means it would take MDA, only 0.55 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.55, MDA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.29 indicates that MDA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.29, MDA is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 0.55 | ||
| Altman-Z | 1.58 |
ROIC/WACC0.61
WACC9.33%
2.3 Liquidity
MDA has a Current Ratio of 0.86. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
MDA has a worse Current ratio (0.86) than 80.00% of its industry peers.
A Quick Ratio of 0.85 indicates that MDA may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.85, MDA is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
MDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.25%, which is quite impressive.
MDA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 185.75% yearly.
MDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.74%.
MDA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.32% yearly.
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)33.74%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
3.2 Future
The Earnings Per Share is expected to grow by 34.67% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 23.76% on average over the next years. This is a very strong growth
EPS Next Y107.77%
EPS Next 2Y49.97%
EPS Next 3Y34.67%
EPS Next 5YN/A
Revenue Next Year52.07%
Revenue Next 2Y31.15%
Revenue Next 3Y23.76%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
MDA is valuated rather expensively with a Price/Earnings ratio of 21.40.
MDA's Price/Earnings ratio is a bit cheaper when compared to the industry. MDA is cheaper than 70.00% of the companies in the same industry.
MDA is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 15.36, MDA is valued correctly.
MDA's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of MDA to the average of the S&P500 Index (36.59), we can say MDA is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.4 | ||
| Fwd PE | 15.36 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDA.
70.00% of the companies in the same industry are more expensive than MDA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.3 | ||
| EV/EBITDA | 11.32 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of MDA may justify a higher PE ratio.
MDA's earnings are expected to grow with 34.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y49.97%
EPS Next 3Y34.67%
5. Dividend
5.1 Amount
MDA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:MDA (11/27/2025, 7:00:00 PM)
24.18
+0.62 (+2.63%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners32.56%
Inst Owner ChangeN/A
Ins Owners1.18%
Ins Owner ChangeN/A
Market Cap3.05B
Revenue(TTM)1.08B
Net Income(TTM)114.70M
Analysts78.33
Price Target41.12 (70.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.62%
Min EPS beat(2)21.08%
Max EPS beat(2)22.16%
EPS beat(4)4
Avg EPS beat(4)29.79%
Min EPS beat(4)19.18%
Max EPS beat(4)56.74%
EPS beat(8)7
Avg EPS beat(8)31.88%
EPS beat(12)11
Avg EPS beat(12)88.39%
EPS beat(16)14
Avg EPS beat(16)87.43%
Revenue beat(2)1
Avg Revenue beat(2)3.32%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)6.87%
Revenue beat(4)3
Avg Revenue beat(4)3.78%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)3.09%
Revenue beat(12)9
Avg Revenue beat(12)2.82%
Revenue beat(16)10
Avg Revenue beat(16)0.84%
PT rev (1m)-6.09%
PT rev (3m)-21.61%
EPS NQ rev (1m)-0.99%
EPS NQ rev (3m)-5.24%
EPS NY rev (1m)-1.23%
EPS NY rev (3m)-2.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-0.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.4 | ||
| Fwd PE | 15.36 | ||
| P/S | 2.25 | ||
| P/FCF | 4.3 | ||
| P/OCF | 3.17 | ||
| P/B | 2.38 | ||
| P/tB | 12.01 | ||
| EV/EBITDA | 11.32 |
EPS(TTM)1.13
EY4.67%
EPS(NY)1.57
Fwd EY6.51%
FCF(TTM)5.62
FCFY23.24%
OCF(TTM)7.63
OCFY31.55%
SpS10.73
BVpS10.17
TBVpS2.01
PEG (NY)0.2
PEG (5Y)N/A
Graham Number16.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 8.94% | ||
| ROCE | 7.95% | ||
| ROIC | 5.72% | ||
| ROICexc | 8.9% | ||
| ROICexgc | 61.78% | ||
| OM | 10.97% | ||
| PM (TTM) | 8.48% | ||
| GM | 24.54% | ||
| FCFM | 52.35% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 0.55 | ||
| Debt/EBITDA | 1.52 | ||
| Cap/Depr | 262.11% | ||
| Cap/Sales | 18.71% | ||
| Interest Coverage | 8.48 | ||
| Cash Conversion | 392.53% | ||
| Profit Quality | 617.7% | ||
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 1.58 |
F-Score6
WACC9.33%
ROIC/WACC0.61
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y107.77%
EPS Next 2Y49.97%
EPS Next 3Y34.67%
EPS Next 5YN/A
Revenue 1Y (TTM)33.74%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
Revenue Next Year52.07%
Revenue Next 2Y31.15%
Revenue Next 3Y23.76%
Revenue Next 5YN/A
EBIT growth 1Y115.07%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year179.33%
EBIT Next 3Y51.75%
EBIT Next 5YN/A
FCF growth 1Y1778.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y628.56%
OCF growth 3Y124.48%
OCF growth 5YN/A
MDA SPACE LTD / MDA.CA FAQ
What is the fundamental rating for MDA stock?
ChartMill assigns a fundamental rating of 6 / 10 to MDA.CA.
What is the valuation status for MDA stock?
ChartMill assigns a valuation rating of 6 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Fairly Valued.
What is the profitability of MDA stock?
MDA SPACE LTD (MDA.CA) has a profitability rating of 6 / 10.
What is the valuation of MDA SPACE LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for MDA SPACE LTD (MDA.CA) is 21.4 and the Price/Book (PB) ratio is 2.38.